# Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study

> **NCT07060482** · — · NOT_YET_RECRUITING · sponsor: **Royal College of Surgeons, Ireland** · enrollment: 240 (estimated)

## Conditions studied

- Gastric Atrophy

## Interventions

- **DIAGNOSTIC_TEST:** Panel of biomarkers including Gastrin 17, pepsinogen 1 and 2, and anti-helicobacter pylori antibodies.

## Key facts

- **NCT ID:** NCT07060482
- **Lead sponsor:** Royal College of Surgeons, Ireland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060482, "Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07060482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*